ROCHESTER, NY, March 22, 2022 – Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that use of its smart glasses within the operating room, as well as for other healthcare use cases, continues to expand as partner firms such as Pixee Medical and Rods&Cones increase their rollout of Vuzix-powered solutions.
Yesterday, Pixee Medical announced that its Knee+ AR computer-assisted orthopedic solution will be commercially launched in the United States, providing a perfect fit for Ambulatory Surgical Centers (ASCs). Launched in Europe and Australia early in 2021, Pixee’s solution will be formally launched in the US at the American Association of Orthopaedic Surgeons (AAOS) Annual Meeting on March 22-26 in Chicago, where the company will meet with surgeons and finalize the organization of its distribution channel.
Additionally, Pixee Medical added that it will soon be adding new features to its Knee+ platform, with soft tissue balancing, kinematic alignment and data connectivity. It will also be expanding its portfolio with a mixed reality product for total shoulder arthroplasty and with an easy-to-use cup orientation and leg length controlling AR tool for total hip arthroplasty. Knee+ is also now compatible with surgical hoods.
Rods&Cones has been a growing consumer of Vuzix M400 smart glasses, which let staff in the operating room, ICU or other medical facility, including surgeons, instrumentalist nurses and other healthcare professionals, provide 4K broadcast quality imagery to others while interacting with patients and staff from a safe distance. To date, Rods&Cones is active in more than 600 hospitals across more than 30 countries and the company anticipates that 2022 will be the year when companies and medical providers start changing their models to prioritize remote technology at the heart of their operations.
Rods&Cones recently announced that its remote access service is compatible with the Pixee Knee+ augmented reality solution for total knee arthroplasty. The compatibility of the two solutions is expected to allow surgeons to use augmented reality during total knee arthroplasty surgeries, while also connecting remotely with other medical experts around the world.
“Firms like Pixee Medical and Rods&Cones are innovators within the healthcare sector and their solutions are facilitating communications and learning, reducing costs, and improving outcomes in operating rooms around the world with the help of Vuzix smart glasses,” said Paul Travers, President and Chief Executive Officer at Vuzix. We look forward to working with these and other providers to help transform the healthcare industry in 2022 and beyond.
Learn more about Rods&Cones here: https://www.rods-cones.com/
Learn more about Pixee Medical here: https://www.pixee-medical.com/en/
About Vuzix Corporation
Vuzix is a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company's products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 245 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2022 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan. For more information, visit the Vuzix website, Twitter and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward-looking statements contained in this release relate to Vuzix Smart Glasses, our business relationship and future opportunities with Pixee Medical and Rods&Cones, and among other things the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Vuzix Media and Investor Relations Contact:
Ed McGregor, Director of Investor Relations,
Vuzix Corporation
Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
Share:
Vuzix Partners with Acty AR Software Solution to Provide Remote Assistance to the Manufacturing Industry
Vuzix Signs Distribution Agreement with Converge IoT That Will Include the Sale of Vuzix Smart Glasses on T-Mobile’s 5G Network